Each year millions of Americans risk undergoing surgery for a variety of problems such as organ transplants, mending broken bones and cosmetic surgeries. Often surgery is necessary to fix ongoing health problems with the benefits of the surgery usually outweighing the risks. Despite the potential risks to surgery patients, in the United States more than 48 million surgeries are performed each year. In most cases, undergoing surgery is relatively risk free, but not always.
Science Market Update
Tags: 2014, Bioscience research, 2013, biomedical research, University of Colorado, Medical Research, Drug Discovery, DNA Research, Southwest, National Jewish Health, Anschutz Medical Campus, BioResearch Product Faire Front Line Event, BioResearch Product Faire Event, Denver, CO, public health, NJH, Fitz, Aurora
The University of California system has five biomedical campuses currently: San Francisco, San Diego, Los Angeles, Irvine, and Davis/Sacramento. While each campus maintains a certain autonomy, the advantage to being part of a unified, statewide system is especially apparent when it comes to sharing resources such as biospecimens. In research studies that require data from large numbers of human blood or tissue samples, for instance, scientists rely on biobanks: an organized collection of human biological material and associated information stored for one or more research purposes.
Tags: CA, University of California Los Angeles, University of California San Francisco, Bioscience research, Bioresearch, Translational Research, Southwest, California, University of California, 2012, Los Angeles, San Diego, San Francisco, BioResearch Product Faire Event, Biotechnology Vendor Showcase
Often growing up as a child you hear, “eat your veggies if you want to grow up to be big and strong.” With new research on triple negative breast cancer, that old saying might have to change to "eat your veggies if you want to keep cancer away". Recently, at the 2012 American Association of Pharmaceutical Scientists (AAPS) Annual Meeting, Mandip Sachdeva announced: "We are confident that the compounds we are currently working with are an effective treatment for triple-negative breast cancer. These compounds are safer for the patient than current treatments available".
Tags: Bioscience research, cancer research, Texas A&M University, Texas, 2012, Cancer Treatment, Cancer, College Station, BioResearch Product Faire Event, Texas A&M Research, Texas A&M Life Science Funding, TX, Texas A&M
|(courtesy of HSC Core Research)|
The Zebrafish may have found their very own fountain of youth, or at least part of their brain has. Neurobiology and Anatomy research professor Richard Dorsky, at the University of Utah, is studying how the Wnt pathway in Zebrafish can grow new nerve cells in the hypothalamus. Researchers have found that Zebrafish can keep on growing new nerve cells even into adulthood. Dorsky's work understanding this mechanism of regeneration in the adult brain could ultimately offer insight into our own neuro-cognitive decline as a result of aging.
In the United States there are approximately 76 million baby boomers, and each year more and more are turning 65 years old. This means that maintaining a healthy functioning brain is becoming a higher and higher priority to a large portion of the population. At this time it seems inevitable that as we age, the normal brain will change physically and cognitively. This year it is estimated it will cost the U.S. $200 billion dollars to care for our 5.4 million Alzheimer’s patients, and the figure is expected to climb higher. In fact, by the year 2050 it is estimated that the cost of Alzheimer’s and other dementias will reach $1.1 trillion dollars. Add the devastating emotional impact on families faced with an elderly parent suffering from the disease, and it's clear why research into neuro-cognitive decline is so important.
It seems that the Dorksy lab is bringing us one step closer to being able to turn back the clock on the human brain. According to Dorsky, "Our research represents a significant contribution to the field because it ... can be used to shed light on the plasticity of the adult brain." Unlike humans, adult Zebrafish have a built in repair system for hypothalamus tissue damage in their brains. The fish’s neural stem cells lie in wait ready to respond to chemical signals of cell damage or death. Part of what makes the Wnt pathway so interesting is that it changes from its embryonic to adulthood. At the embryo stage, Wnt signaling is essentially an on switch that tells the neural stem cells to rapidly grow. This causes the rapid increase of progenitor cells. The progenitor cells arise from neural stem cells. With more development the progenitor cells differentiate into the brain's structures. But this changes in adult Zebrafish when the Wnt pathway becomes radically different.
(courtesy of Dorsky lab)
|(Courtesy of Dorsky lab)|
In a recent article by Dorsky, Wnt signaling regulates postembryonic hypothalamic progenitor differentiation, he describes how his lab research determined how the Wnt pathway in adult zebrafish signals cell regeneration. In adults, the Wnt has to have perfect timing in order for the progenitor cells to grow and differentiate. The Wnt pathway has to first turn on to start the growth and differentiation, then later turn off again to grow properly. It can’t just stay on.
Moreover, the lab studied mice in order to see how the Wnt pathway translates in other animal models. The researcher found that the wnt pathway in mice acts to stop the differentiation of glial cells. Moreover according to Dorsky: "In adult mice, hypothalamic neurogenesis seems to be significant in the regulation of feeding behaviors due to environmental changes."
So, the sooner we can find a cure for Neuro cognitve decline and turn back the time on our aging brain the better we will all be. So, with the help of a little fish, in the future we might be able to grow new neuro tissue in the hypothalamus. Who knew that the Zebrafish light lead us to our own neuro fountain of youth.
Members of the Dorsky lab include:
|(Courtesy of Dorsky lab)|
-Lisa Benko- Graduate Student-Characterization of Multipotent Spinal Cord Progenitors
-Rob Duncan- graduate student- Identification of Neural Stem Cells in the Zebrafish Hypothalamus
-Hyung-Seok Kim-Postdoctoral-Fellow-Tcf3 Targets in Spinal Cord Development
-Adam McPherson-Graduate-Student-Functional Analysis of Post-Embryonic Hypothalamic Neurogenesis
-Xu Wang-graduate student-lab manager- Wnt Signaling and Post-Embryonic Hypothalamic Neurogenesis
The Dorsky lab is part of the Department of Neurobiology and Anatomy which is located in the Wintrobe building adjacent to the school of medicine. The department occupies 17,000 square feet and has 13 department faculty researching: developmental biology, neuroscience, stem cells and regeneration, and neural disease and repair. The department currently uses several different animal models in its research: mouse, chicken, zebrafish, xenopus, and planaria.
Biotechnology Calendar, Inc. will be holding its 13th Annual Salt Lake BioResearch Product Faire Front Line event next on August 15, 2013. This professional show is an excellent opportunity for life scientists and lab equipment specialists to come together and discuss lab technologies to make every lab run at maximum efficiency. If you are unable to make it to our Utah show, these are other shows you might me interested in attending.
- 02/01/2013 13th Annual Houston BioResearch Product Faire™, located in Houston and situated at the Texas Medical Center.
- 02/06/2013- 8th Annual Mission Bay Biotechnology Vendor Showcase™ located in San Francisco and situated on the UC San Francisco Campus
- 06/20/2013 - 4th Annual Denver BioResearch Product Faire™ at the University of Colorado, Anschutz Medical Campus.
One of the things they got was some very thoughtfully designed labs. Though flexibility of design is important to assure future utility, research team leaders gave significant input into the design of their specific labs to make sure those labs were ideal for the type of research that would be carried out within their walls. Project architect Tim Williams, of Zimmer Gunsul Frasca, said in an interview:
“Scientists spend a lot of time in the lab. The UW faculty wanted to look at how we could make that a nicer place to be."
Here are some of the ways they made a nicer science lab building:
- 5-story, 90,300sf structure
- Each of the four above-ground floors is divided into a laboratory half and an office half
- The basement is a 28,000sf low-vibration lab space
- Houses more than 15 faculty, 3 research centers and 4 major instrumentation centers
- Aluminum-plate shielding on the building guards against electromagnetic waves
- Natural ventilation in office spaces provided by windows that open
- Optimized ventilation in the lab spaces, replacing air 6 times per hour rather than 10
- Innovative commons spaces
- Green roof gardens
UW officials are proud of the new building, not just because it is state-of-the-art, but also because it's "state-of-the-science." Molecular engineering is a relatively new field, and the UW Molecular Engineering and Sciences Institute (MOLES, the building's primary occupant) sees its mission as exploring a new kind of engineering for the 21st Century: rather than build bridges over rivers (still a noble feat), the new molecular engineer may be building proteins that travel to specific parts of the body. He or she may follow the latest developments in chemistry, biology, physics, nanotechnology and predictive modeling; and his or her research projects will often be interdisciplinary, with colleagues from diverse fields and perhaps different institutions.
Furthermore, if life scientists often pursue basic research to understand the building blocks of life, and engineers build things and occupy themselves with practical mechanics and physical principles, the fusion of the two should have tremendous translational potential. Such is the goal of MOLES and their new collaborative workspace. Per their website:
Research at the Institute for Molecular Engineering & Sciences will be evolvable and dynamic, focusing initially on the themes of CleanTech and BioTech.
Some of the faculty scientists who will be doing research in the new MOLES facility include:
- Patrick Stayton, a professor of bioengineering
- Suzie Pun, a bioengineering associate professor
- David Baker, a biochemistry professor
- Daniel Gamelin, a chemistry professor
- Hugh Hillhouse, a chemical engineering professor
- Christine Luscombe, an associate professor of materials science and engineering
(Dr. David Baker seems to come up in our blog series with regularity. For former blogs citing his work, read the following:)
Biotechnology Calendar, Inc. will hold 3 professional tradeshow events focusing on Washington state's bioscience technology and the research partnerships between scientists and the science equipment industry next month on these dates:
- 10/23/2012 -- Washington State University BioResearch Product Faire event, Pullman
- 10/24/2012 -- Fred Hutchinson Cancer Research Center BRPF event, Seattle
- 10/25/2012 -- University of Washington Front Line event, Seattle
For information on exhibiting at the University of Washington show in particular, and receiving a university research funding report, click here:
Biotechnology Calendar, Inc. is a full service event marketing and planning company producing on-campus, life science research tradeshows nationwide for the past 20 years. We plan and promote each event to bring the best products and services to the best research campuses across the country.
Tags: Bioscience research, CEEM, UW, Molecular Engineering, University of Washington, Northwest, WSU, New research facilities, 2012, Biochemistry, chemistry research, Engineering, Front Line event, Energy, Seattle, new construction, construction
Washington University in St Louis (WUSTL) has just received a $2M research grant that will go towards combating a disorder which afflicts, often fatally, nearly 5.8 million Americans each year: heart failure. Heart failure is one of the leading causes of death in the US and although many promising drugs have been introduced over the years, we have yet to find a definitive treatment for the variety of cases that doctors encounter. This $2M NIH award wil go to a team of WUSTL scientists for basic research that will contribute to our understanding of heart disease and ideally lead to more effective treatment. The end goal of this research project is the design and construction of artificial tissue models of the heart, which will allow scientists to more quickly and efficiently test new drugs.
Tags: Bioscience research, Midwest, biomedical sciences, biomedical research, Bioresearch, Washington University, Missouri, WUSTL, heart disease, 2012, Biochemistry, BioResearch Product Faire Event, Research, NIH, MO, St Louis, BRPF, basic research funding
Biomedical science researchers have worked tirelessly at the University of California, Riverside since the discovery of a crucial link involving mice, humans, and Alzheimer's disease. Back in 2006, UCR researchers, in a collaborative effort with the University of South Florida, discovered an interesting connection between the immune system and Alzheimer's disease while experimenting on lab mice. Professor Douglas Ethell, the assistant professor of Biomedical Sciences at UCR, along with the USF's own Professor Gary Arendash of the Johnnie B. Byrd Institute, was instrumental in this find.
University of Cincinnati College of Medicine molecular geneticist Daniel Hassett (right) has made a name for himself as a determined researcher in the fight against cystic fibrosis (CF). He is also on the front line of bioscience research into creating "superbugs" that eat waste and generate energy, improving dramatically on the efficiency of traditional waste water treatment systems. In a radio interview on WVXU Cincinnati's Focus on Technology, commentator Ann Thompson describes the problem: the largest user of energy is wastewater treatment; the second largest user of water is energy production. If you can find a way to both clean water and generate electricity, you're in business.
Tags: Bioscience research, Midwest, Ohio, biomedical research, University of Cincinnati, genetic engineering, molecular ecology research, BioResearch Product Faire Event, Cincinnati, BRPF, research scientist
Debates over the legitimacy of medical marijuana as a pain medication or appetite enhancer have tended to point to a lack of scientific studies proving the key substance is safe and effective. Patients and doctors have not always waited for that hard evidence, instead working from an empirical position that saw positive results from the ingestion of cannabinoids, the active ingredients, that lead them to make their own treatment decisions. But serious bioscience research, especially in the fields of pharmacology, infectious disease, and neuroscience, is showing surprising results in laboratory studies on cannabinoids, and those findings go far beyond the pain and appetite benefits to actually short-circuiting disease in late-stage AIDS patients.